LONDON -- The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The task force determines which preventive services insurers must cover at no cost to patients.

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

Ending the spread of HIV in Arizona may become more difficult if federal funding is cut or eliminated. Phoenix is trying to ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, ...

The Trump administration is considering a dramatic cutback and eventual phasing out of the President’s Emergency Plan for ...

When Robert Smith met his future girlfriend in 2010, he wanted to take things slowly. For Smith, no relationship had been ...